메뉴 건너뛰기




Volumn 919-920, Issue , 2013, Pages 1-9

Simultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography-tandem mass spectrometry

Author keywords

Antibiotics; Antifungals; Imatinib; LC MS MS; Raltegravir

Indexed keywords

ACTIVE METABOLITES; ANTIFUNGALS; ANTINEOPLASTIC AGENTS; ANTIRETROVIRALS; CIPROFLOXACIN; DAPTOMYCIN; ELECTROSPRAYS; EXTRACTION RECOVERY; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; HUMAN PLASMAS; IMATINIB; INTER-ASSAY COEFFICIENTS; INTERNAL QUALITY; ION SUPPRESSION; ITRACONAZOLE; LC-MS/MS; LEVOFLOXACIN; MATRIX EFFECTS; POSITIVE MODE; PROTEIN PRECIPITATION; QUADRUPOLE MASS SPECTROMETRY; RALTEGRAVIR; RESOURCE UTILIZATIONS; SELECTED REACTION MONITORING; THERAPEUTIC DRUG MONITORING; VORICONAZOLE;

EID: 84873267092     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.12.028     Document Type: Article
Times cited : (70)

References (56)
  • 48
    • 84873267251 scopus 로고    scopus 로고
    • U.S. Department of Health and Human Services Food and Drug Administration, Guidance for Industry Bioanalytical Method Validation, (23.04.08)
    • U.S. Department of Health and Human Services Food and Drug Administration, Guidance for Industry Bioanalytical Method Validation, (23.04.08), 2001. http://www.fda.gov/CDER/GUIDANCE/4252fnl.htm.
    • (2001)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.